Minzasolmin
Minzasolmin is a pharmaceutical drug with 2 clinical trials. Historical success rate of 50.0%.
Registry-listed formulations
Minzasolmin · chembl:CHEMBL5095072
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
4 source entries across 2 studies. This list may not include all unresolved or historical entries.
- Minzasolmin (UCB0599)Registry intervention
Linked study entry; product equivalence not established
View study and source - UCB0599 PRD4385815Registry product
Named ingredient; product remains distinct
Formulation reported by source: CAPSULE, HARD
Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.
View study and source - MinzasolminRegistry product
Named ingredient; product remains distinct
Formulation reported by source: FILM-COATED TABLET
Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.
View study and source - UCB0599 PRD4385815Registry product
Named ingredient; product remains distinct
Formulation reported by source: CAPSULE, HARD
Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.
View study and source
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
0
trials recruiting
2
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants
Clinical Trials (2)
An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants
All 2 trials loaded
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 2